Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

AstraZeneca (LSE:AZN) takes about 12% of Summit Therapeutics in $2bn share investment and ivonescimab trial pact

In an announcement on 29 September 2026, AstraZeneca set out two linked agreements with Summit Therapeutics Inc. The first is a $2bn strategicInvestmentin newly issued Summit stock. The second is a clinical collaboration to test Sone-Ve with ivonescimab in gastrointestinal cancers.

Ankur Sharma | 30 September 2026

Why Is Oxford BioMedica (LSE:OXB) in Focus Despite Continued Revenue Growth?

Oxford BioMedica is a specialist cell-and-gene-therapy contract development andManufacturingorganisation. ItsInvestmentcase is linked to theLong-term Growthof advanced therapies and the increasing need for specialist manufacturing capacity. First-half 2026 results showed 10% constant-currency revenue growth to £80.2 million, while management reiterated full-year and medium-term guidance.

Ankur Sharma | 30 September 2026

Spire Healthcare Takeover Moves Forward: Why Is LSE:SPI in Focus as Investors Assess the £2.2 Billion Deal? (LSE:SPI)

Spire Healthcare —LSE:SPI— is attracting attention as its proposed acquisition moves into another important stage.

Ankur Sharma | 30 September 2026

Coiled Therapeutics Reports Interim Results as Gene-Editing Pipeline Advances: Why Is LSE:COIL in Focus? (LSE:COIL)

Coiled Therapeutics —LSE:COIL— is attracting attention after publishing its latest interim results, giving investors an updated view of its financial position and progress across its gene-editing pipeline.

Ankur Sharma | 30 September 2026

AstraZeneca Announces $2 Billion Summit Investment: Why Is LSE:AZN in Focus as Cancer Drug Development Accelerates? (LSE:AZN)

AstraZeneca —LSE:AZN— has moved into focus following its agreement to invest$2 billion in newly issued equity of Summit Therapeutics.

Ankur Sharma | 30 September 2026

Why Is Venture Life Group plc (LSE:VLG) in Focus After a 5.43% Fall on 29 September 2026?

Venture Life released final results on 29 September 2026 for the 17-month period ended 31 May 2026 and also announced a chief executive succession. Earlier trading information indicatedRevenueof £50.0 million for the period, up 30.9%, with pro-forma growth of 16.0%. In the final five …

Ankur Sharma | 30 September 2026

How Nuformix (LSE:NFX) Advanced Its Inhaled Lung Fibrosis Drug NXP002 in Preclinical Work

Nuformix (LSE:NFX) describes itself as a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology through drug repurposing, developing new formulations of existing compounds with improved properties. Its shares trade on theLondon Stock ExchangeMain Market under the code NFX. The company's lead …

Ankur Sharma | 29 September 2026

Why Avacta Group (LSE:AVCT) Is Highlighting New AVA6103 Data for Pancreatic Cancer

Avacta (LSE:AVCT) describes itself as a clinical-stage life sciences company developing targeted cancer therapies. Its pre|CISION technology attaches a potent chemotherapy payload to a peptide that is cleaved by fibroblast activation protein (FAP), an enzyme found in high concentrations in the tumour microenvironment. The …

Ankur Sharma | 29 September 2026

Why Oxford BioDynamics (LSE:OBD) Raised £9.15 Million to Fund Its EpiSwitch Diagnostics

Oxford BioDynamics, spun out of the University of Oxford in 2007, develops blood tests and research tools built on EpiSwitch, a proprietary platform that maps the three-dimensional architecture of the genome. Its commercial tests include the PSE test for prostate cancer detection and CiRT, …

Ankur Sharma | 29 September 2026

CT Healthcare Trust (LSE:CTHT) Turns to Quarterly Tender Offers Following Its Manager Change

The company invests in global healthcare stocks. It was previously known as Bellevue Healthcare Trust plc, and according to its change-of-name announcement of 24 March 2026, it adopted the CT Healthcare Trust name with effect from 19 March and began trading on the Main …

Divya Sood | 29 September 2026
Support

Hi! How can we help you today?

Loading…